Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Sell
38
CHLSY Quote, Financials, Valuation and Earnings
Last price:
$13.50
Seasonality move
:
5.43%
Day range:
$13.33 - $13.84
52-week range:
$10.05 - $14.32
Dividend yield:
1.13%
P/E ratio:
41.30x
P/S ratio:
5.09x
P/B ratio:
5.81x
Volume:
11.4K
Avg. volume:
13K
1-year change:
12.03%
Market cap:
$31.1B
Revenue:
$6.2B
EPS (TTM):
$0.33
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Chocoladefabriken Lindt & Spruengli AG has -- downside to fair value with a price target of -- per share.
CHLSY vs. S&P 500
-
Over the past 5 trading days, Chocoladefabriken Lindt & Spruengli AG has overperformed the S&P 500 by 0.68% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Chocoladefabriken Lindt & Spruengli AG does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Chocoladefabriken Lindt & Spruengli AG has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Chocoladefabriken Lindt & Spruengli AG reported revenues of --.
Earnings Growth
-
Chocoladefabriken Lindt & Spruengli AG has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Chocoladefabriken Lindt & Spruengli AG reported earnings per share of --.
Enterprise value:
31.4B
EV / Invested capital:
4.70x
Price / LTM sales:
5.09x
EV / EBIT:
31.02x
EV / Revenue:
5.10x
PEG ratio (5yr expected):
1.30x
EV / Free cash flow:
31.84x
Price / Operating cash flow:
31.77x
Enterprise value / EBITDA:
23.32x
Gross Profit (TTM):
$4B
Return On Assets:
8.03%
Net Income Margin (TTM):
12.32%
Return On Equity:
14.92%
Return On Invested Capital:
11.87%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-29 | 2024-03-29 | 2024-03-29 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.4B | $3.3B | $3.1B | $3.1B | $3.9B | |
| Total Assets | $9.2B | $9.8B | $8.6B | $9.4B | $10.1B | |
| Current Liabilities | $1.5B | $1.6B | $1.7B | $2.2B | $2.2B | |
| Total Liabilities | $3.9B | $4.1B | $3.8B | $4.3B | $4.8B | |
| Total Equity | $5.3B | $5.7B | $4.7B | $5.1B | $5.4B | |
| Total Debt | $1.1B | $1.1B | $1.1B | $1.2B | $1.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-29 | 2024-03-29 | 2024-03-29 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
CHLSY
Sector
Market Cap
$31.1B
--
Price % of 52-Week High
94.27%
--
Dividend Yield
1.13%
--
Shareholder Yield
1.59%
--
1-Year Price Total Return
12.03%
--
Beta (5-Year)
--
--
Dividend yield:
1.13%
Annualized payout:
$0.15
Payout ratio:
46.91%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$13.44
200-day SMA
Buy
Level
$12.18
Bollinger Bands (100)
Buy
Level
10.92 - 12.76
Chaikin Money Flow
Sell
Level
-1.2M
20-day SMA
Buy
Level
$13.45
Relative Strength Index (RSI14)
Buy
Level
56.71
ADX Line
Buy
Level
18.05
Williams %R
Neutral
Level
-31.7757
50-day SMA
Buy
Level
$12.40
MACD (12, 26)
Buy
Level
0.29
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
233.5K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.2042)
Buy
CA Score
(Annual)
Level (0.4165)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.3446)
Buy
Piotroski F Score
(Annual)
Level (5)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Swiss-based Chocoladefabriken Lindt & Spruengli is a manufacturer of premium chocolate. Key brands include Lindt, Lindor, Ghirardelli, Russell Stover, Whitman's, and Caffarel. The company bought US-based Russell Stover, its largest-ever acquisition, in 2014. It derives the bulk of its sales from Europe (46% of its consolidated base) but also competes in North America (41%) and the rest of the world (13%). The company operates 11 manufacturing plants in Europe and the United States. Its distribution network includes 500 own stores.
Stock Forecast FAQ
In the current month, CHLSY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CHLSY average analyst price target in the past 3 months is --.
-
Where Will Chocoladefabriken Lindt & Spruengli AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Chocoladefabriken Lindt & Spruengli AG share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Chocoladefabriken Lindt & Spruengli AG?
Analysts are divided on their view about Chocoladefabriken Lindt & Spruengli AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Chocoladefabriken Lindt & Spruengli AG is a Sell and believe this share price will rise from its current level to --.
-
What Is Chocoladefabriken Lindt & Spruengli AG's Price Target?
The price target for Chocoladefabriken Lindt & Spruengli AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CHLSY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Chocoladefabriken Lindt & Spruengli AG is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CHLSY?
You can purchase shares of Chocoladefabriken Lindt & Spruengli AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Chocoladefabriken Lindt & Spruengli AG shares.
-
What Is The Chocoladefabriken Lindt & Spruengli AG Share Price Today?
Chocoladefabriken Lindt & Spruengli AG was last trading at $13.50 per share. This represents the most recent stock quote for Chocoladefabriken Lindt & Spruengli AG. Yesterday, Chocoladefabriken Lindt & Spruengli AG closed at $13.50 per share.
-
How To Buy Chocoladefabriken Lindt & Spruengli AG Stock Online?
In order to purchase Chocoladefabriken Lindt & Spruengli AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
85
SLNO alert for Mar 29
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
